ECIL guidelines for preventingPneumocystis jiroveciipneumonia in patients with haematological malignancies and stem cell transplant recipients

Pneumocystis jiroveciipneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients

(2016) Catherine Cordonnier et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Single-Day Trimethoprim/Sulfamethoxazole Prophylaxis for Pneumocystis Pneumonia in Children with Cancer

(2013) Désirée Caselli et al.   JOURNAL OF PEDIATRICS

Therapeutic Potential of Caspofungin Combined with Trimethoprim-Sulfamethoxazole for Pneumocystis Pneumonia: A Pilot Study in Mice

(2013) Maria Luísa Lobo et al.   PLoS One

Dapsone-induced methemoglobinemia

(2011) Adam J. Esbenshade et al.   CANCER

Pneumocystis jiroveci pneumonia prophylaxis during maintenance therapy influences methotrexate/6-mercaptopurine dosing but not event-free survival for childhood acute lymphoblastic leukemia

(2011) Mette Levinsen et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Pneumocystis jiroveciiinfection: Cell wall (1→3)-β-D-glucan biology and diagnostic utility

(2010) Malcolm A. Finkelman   CRITICAL REVIEWS IN MICROBIOLOGY

Twice Weekly Pneumocystis jiroveci Pneumonia Prophylaxis With Trimethoprim-Sulfamethoxazole in Pediatric Patients With Acute Lymphoblastic Leukemia

(2010) Anurag K. Agrawal et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Breakthrough cerebral toxoplasmosis in a patient receiving atovaquone prophylaxis after a hematopoietic stem cell transplantation

(2010) Orli Megged et al.   PEDIATRIC TRANSPLANTATION

Echinocandin Treatment of Pneumocystis Pneumonia in Rodent Models Depletes Cysts Leaving Trophic Burdens That Cannot Transmit the Infection

(2010) Melanie T. Cushion et al.   PLoS One

A Systematic Review of Two Different Trimetoprim–Sulfamethoxazole Regimens Used to Prevent Pneumocystis jirovecii and No Prophylaxis at All in Transplant Recipients: Appraising the Evidence

(2009) P. Di Cocco et al.   TRANSPLANTATION PROCEEDINGS

Intermittent oral trimethoprim/sulfamethoxazole on two non-consecutive days per week is effective asPneumocystis jirovecipneumonia prophylaxis in pediatric patients receiving chemotherapy or hematopoietic stem cell transplantation

(2008) Yasuhisa Ohata et al.   PEDIATRIC BLOOD & CANCER

Pneumocystis pneumonia in children receiving chemotherapy

(2007) Pinki Prasad et al.   PEDIATRIC BLOOD & CANCER

Intravenous pentamidine is effective as second linePneumocystis pneumonia prophylaxis in pediatric oncology patients

(2007) Su Young Kim et al.   PEDIATRIC BLOOD & CANCER